STOCK TITAN

[4] – VARON LESLIE F (CIK 0001207403)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

DENTSPLY SIRONA (XRAY) director reported an equity accrual. On 10/10/2025, the reporting person acquired 179.449 units at $0, reflecting dividends credited on previously awarded RSUs that carry the same vesting terms. Each RSU converts to common stock on a 1:1 basis.

Following this transaction, beneficial ownership stood at 48,005.925 on a direct basis. These credits represent routine dividend equivalents tied to outstanding RSUs rather than open‑market purchases.

DENTSPLY SIRONA (XRAY) il direttore ha registrato un accrual azionario. Il 10/10/2025 la persona che segnala ha acquisito 179.449 unità a $0, riflettendo dividendi accreditati su RSU precedentemente assegnate che hanno gli stessi termini di vesting. Ogni RSU si converte in azioni ordinarie con un rapporto 1:1.

Dopo questa operazione, la proprietà benefica è risultata pari a 48.005.925 in modo diretto. Questi crediti rappresentano equivalenti di dividendi di routine legati a RSU pendenti anziché acquisti sul mercato aperto.

DENTSPLY SIRONA (XRAY) un director informó un incremento patrimonial. El 10/10/2025, la persona que reporta adquirió 179.449 acciones a $0, reflejando dividendos acreditados sobre RSU otorgadas previamente que tienen los mismos términos de vesting. Cada RSU se convierte en acciones comunes en una base de 1:1.

Tras esta transacción, la titularidad beneficiosa fue de 48.005.925 de forma directa. Estos créditos representan equivalentes de dividendos rutinarios vinculados a RSU pendientes en lugar de compras en el mercado abierto.

DENTSPLY SIRONA (XRAY) 이사는 주식 누적액을 보고했습니다. 2025년 10월 10일, 보고자는 179.449주를 0달러에 취득했으며, 이는 동일한 vesting 조건을 가진 이전에 부여된 RSU에 적립된 배당금을 반영합니다. 각 RSU는 1:1의 비율로 보통주로 전환됩니다.

이 거래 이후 직접적으로 유익한 소유권은 48,005.925주로 남아 있었습니다. 이 크레딧은 공개시장 매입이 아니라 미결 RSU와 관련된 일상적인 배당금 등가액을 나타냅니다.

Le directeur de DENTSPLY SIRONA (XRAY) a rapporté un accrual d'actions. Le 10/10/2025, la personne qui communique a acquis 179,449 actions à 0 USD, reflétant des dividendes crédités sur des RSU attribuées précédemment qui suivent les mêmes conditions de vesting. Chaque RSU se convertit en actions ordinaires à raison de 1 pour 1.

À l’issue de cette transaction, la propriété bénéficiaire s’élevait à 48,005.925 en ligne directe. Ces crédits représentent des équivalents de dividendes habituels liés à des RSU en circulation plutôt que des achats sur le marché libre.

Ein Direktor von DENTSPLY SIRONA (XRAY) meldete eine Eigenkapitalzufuhr. Am 10.10.2025 erwarb die meldende Person 179,449 Anteile zu 0 USD, was Dividenden widerspiegelt, die auf zuvor zugewiesene RSUs angerechnet wurden, die dieselben Vesting-Bedingungen tragen. Jeder RSU wandelt sich 1:1 in Stammaktien um.

Nach dieser Transaktion belief sich der wirtschaftlich berechtigte Eigentum direkt auf 48.005.925 Anteile. Diese Gutschriften stellen routinemäßige Dividendengleichwerte dar, die mit ausstehenden RSUs verbunden sind, statt Open-Market-Käufen.

أبلغ مدير في DENTSPLY SIRONA (XRAY) عن تراكم حقوق الملكية. في 10/10/2025، قام الشخص المبلغ عن الاستثمار باكتساب 179.449 وحدة بسعر 0 دولار، مع عكس أرباح الأسهم الموزعة على RSUs الممنوحة سابقاً والتي تحمل نفس شروط vesting. كل RSU يتحوّل إلى أسهم عادية بنسبة 1:1.

بعد هذه المعاملة، بلغت الملكية المادية الفعالة مباشرة 48,005.925 سهمًا. تمثل هذه الاعتمادات مكافئات أرباح توزيعية روتينية مرتبطة بـ RSUs القائمة وليست مشتريات في السوق المفتوحة.

DENTSPLY SIRONA (XRAY) 的一位董事报告了股权累计。 于 2025 年 10 月 10 日,报告人以 0 美元购买了 179.449 股,反映了对先前授予的 RSU 的分红记入,这些 RSU 具有相同的归属条件。每个 RSU 以1:1 的比例转换为普通股。

完成此交易后,受益所有权直接为 48,005.925 股。这些记入额表示与在外 RSU 相关的常规股息等价物,而非公开市场购买。

Positive
  • None.
Negative
  • None.

DENTSPLY SIRONA (XRAY) il direttore ha registrato un accrual azionario. Il 10/10/2025 la persona che segnala ha acquisito 179.449 unità a $0, riflettendo dividendi accreditati su RSU precedentemente assegnate che hanno gli stessi termini di vesting. Ogni RSU si converte in azioni ordinarie con un rapporto 1:1.

Dopo questa operazione, la proprietà benefica è risultata pari a 48.005.925 in modo diretto. Questi crediti rappresentano equivalenti di dividendi di routine legati a RSU pendenti anziché acquisti sul mercato aperto.

DENTSPLY SIRONA (XRAY) un director informó un incremento patrimonial. El 10/10/2025, la persona que reporta adquirió 179.449 acciones a $0, reflejando dividendos acreditados sobre RSU otorgadas previamente que tienen los mismos términos de vesting. Cada RSU se convierte en acciones comunes en una base de 1:1.

Tras esta transacción, la titularidad beneficiosa fue de 48.005.925 de forma directa. Estos créditos representan equivalentes de dividendos rutinarios vinculados a RSU pendientes en lugar de compras en el mercado abierto.

DENTSPLY SIRONA (XRAY) 이사는 주식 누적액을 보고했습니다. 2025년 10월 10일, 보고자는 179.449주를 0달러에 취득했으며, 이는 동일한 vesting 조건을 가진 이전에 부여된 RSU에 적립된 배당금을 반영합니다. 각 RSU는 1:1의 비율로 보통주로 전환됩니다.

이 거래 이후 직접적으로 유익한 소유권은 48,005.925주로 남아 있었습니다. 이 크레딧은 공개시장 매입이 아니라 미결 RSU와 관련된 일상적인 배당금 등가액을 나타냅니다.

Le directeur de DENTSPLY SIRONA (XRAY) a rapporté un accrual d'actions. Le 10/10/2025, la personne qui communique a acquis 179,449 actions à 0 USD, reflétant des dividendes crédités sur des RSU attribuées précédemment qui suivent les mêmes conditions de vesting. Chaque RSU se convertit en actions ordinaires à raison de 1 pour 1.

À l’issue de cette transaction, la propriété bénéficiaire s’élevait à 48,005.925 en ligne directe. Ces crédits représentent des équivalents de dividendes habituels liés à des RSU en circulation plutôt que des achats sur le marché libre.

Ein Direktor von DENTSPLY SIRONA (XRAY) meldete eine Eigenkapitalzufuhr. Am 10.10.2025 erwarb die meldende Person 179,449 Anteile zu 0 USD, was Dividenden widerspiegelt, die auf zuvor zugewiesene RSUs angerechnet wurden, die dieselben Vesting-Bedingungen tragen. Jeder RSU wandelt sich 1:1 in Stammaktien um.

Nach dieser Transaktion belief sich der wirtschaftlich berechtigte Eigentum direkt auf 48.005.925 Anteile. Diese Gutschriften stellen routinemäßige Dividendengleichwerte dar, die mit ausstehenden RSUs verbunden sind, statt Open-Market-Käufen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
VARON LESLIE F

(Last) (First) (Middle)
C/O DENTSPLY SIRONA INC
13320-B BALLANTYNE CORPORATE PLACE

(Street)
CHARLOTTE NC 28277

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/10/2025 A 179.449(1) A $0 48,005.925 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
/s/ Jessica Nielsen Causey, Attorney-in-Fact for Leslie F. Varon 10/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Dentsply Sirona Inc

NASDAQ:XRAY

XRAY Rankings

XRAY Latest News

XRAY Latest SEC Filings

XRAY Stock Data

2.52B
198.69M
0.39%
104.2%
3.83%
Medical Instruments & Supplies
Dental Equipment & Supplies
Link
United States
CHARLOTTE